Order Article Reprints

Baun C, Mitran B, Rinne SS, Dam JH, Olsen BB, Tolmachev V, Orlova A, Thisgaard H. Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer. Molecules. 2020; 25(24):5993. https://doi.org/10.3390/molecules25245993

Baun, Christina, Bogdan Mitran, Sara S. Rinne, Johan H. Dam, Birgitte B. Olsen, Vladimir Tolmachev, Anna Orlova, and Helge Thisgaard. 2020. "Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer" Molecules 25, no. 24: 5993. https://doi.org/10.3390/molecules25245993

Baun, C., Mitran, B., Rinne, S. S., Dam, J. H., Olsen, B. B., Tolmachev, V., Orlova, A., & Thisgaard, H. (2020). Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer. Molecules, 25(24), 5993. https://doi.org/10.3390/molecules25245993